Amylin Pharmaceuticals News

The presentation will be webcast through the "Investors" section of Amylin's corporate website at www.amylin.com , and a recording will be made available following the event.

There are relatively few drug companies that offer a truly balanced opportunity for investors.

The Cincinnati Metro New In Town Meetup group will hold a social networking event at Brazenhead Irish Pub on Saturday, Feb.

Diabetes drug maker Amylin Pharmaceuticals Inc., which employs 300 in West Chester, reported a larger fourth-quarter loss after it ended a partnership with Eli Lilly & Co., giving Amylin all the rights to the newly approved, once-weekly diabetes injection Bydureon.

Investment analysts at Bank of America upped their price target on shares of Amylin Pharma to $18.00 in a note issued to investors on Wednesday.

Separately, analysts at Jefferies Group reiterated a "buy" rating on shares of Amylin Pharma in a research note to investors on Tuesday.

Humana Inc. : After Humana reported higher than expected Q4 EPS, Oppenheimer believes that the company's guidance was favorable while its growth outlook remains intact.

Tesla Motors, Inc. : Barclays believes Tesla's new Model X SUV launch will highlight its innovation capabilities and differentiation.

True Religion Apparel Inc. : Benchmark Co. raised its price target for True Religion citing management's strong execution ahead of the company's earnings on February 9. The firm keeps a Buy rating on the stock.

Novo Nordisk reported earnings of $1.51 per American Depository Receipt , in the fourth quarter 2011, much above the Zacks Consensus Estimate of $1.24. Earnings were also ahead of the prior-year earnings of $1.35 per ADR.

Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets.

Welcome to the Amylin Pharmaceuticals Q4 2011 Earnings Call. [Operator Instructions] This conference is being recorded.

"Our strong execution in 2011 has positioned us to enter 2012 with an extraordinary opportunity to maximize shareholder value.

Analysts at Imperial Capital decreased their price target on shares of Amylin Pharma to $7.50 in a research report issued to clients and investors on Monday.

Salesforce.com : After conducting checks, BMO Capital reports that its sources were upbeat about Salesforce.com's January quarter.

The first once-weekly treatment for type 2 diabetes will be made in West Chester Township, according to a recent press release from Amylin Pharmaceuticals .

Last Friday, the Food and Drug Administration finally approved Bydureon, a once-weekly diabetes shot developed by Amylin Pharmaceuticals and Alkermes PLC .

The World Health Organization says the highest levels ever of drug-resistant tuberculosis have been found in Russia and Moldova.

Alkermes plc recently announced the commencement of an open-label pilot study of Vivitrol in adult prisoners who have a history of pre-incarceration of opioid dependence, a chronic brain disorder.

The single, easiest way to keep track of all the stocks that matter... Your own personalized stock watchlist! It's a 100% FREE Motley Fool service... Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.